Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Last updated: 2024
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 15 of 72 items.
Unauthorized injectable drug products sold illegally on Quadragen and Advanced Research websites may pose serious health risks
AlertPublic advisory | 2024-06-26
Nomad Hand Sanitizer: Incorrect Expiry Date
RecallHealth product recall | 2024-06-26
Unauthorized workout supplements may pose serious health risks
AlertPublic advisory | 2024-06-25
Unauthorized sexual enhancement products may pose serious health risks
AlertPublic advisory | 2024-06-25
JAMP-Doxazosin 4 mg: The uniformity of dosage unit may be out of specification in the affected lot.
RecallHealth product recall | 2024-06-25
TEVA-ECTOSONE: Presence of contaminant (degradant) in affected lot.
RecallHealth product recall | 2024-06-21
Dianeal PD4 2.5% Dextrose and Physioneal 40 2.27% Glucose peritoneal dialysis solutions recalled due to risk of leakage at connection site
RecallHealth product recall | 2024-06-14
XQS Nicotine Pouches 4 & 6 mg: No market authorization
RecallHealth product recall | 2024-06-13
Poppers are unauthorized and may pose serious health risks
AlertPublic advisory | 2024-06-13
Zyn Nicotine Pouches 1.5 & 3mg: No market authorization
RecallHealth product recall | 2024-06-12
Taisho Pharmaceutical Pabron Gold A (Granules) unlicensed product:, product is labelled to contain dihydrocodeine phosphate that is listed on Schedule I of the CDSA
RecallHealth product recall | 2024-06-10
PMS-PIRFENIDONE 267 & 801 mg: Data integrity concerns with products bioequivalence data that could lead to incorrect dosing.
RecallHealth product recall | 2024-06-07
Important Safety and Efficacy Information on ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine) – Market Withdrawal and Continued Restricted Access
AlertHealth professional risk communication | 2024-06-07
Accel-Ondansetron ODT, Mint-Betahistine and PMS-Pirfenidone tablets recalled due to data integrity concerns
AlertPublic advisory | 2024-06-07